Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
Regression Toward the Mean01:52

Regression Toward the Mean

Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when researchers try to extrapolate results...
Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses01:25

Determination of Multiple Dosing Parameters: Loading and Maintenance Doses

A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
Pharmacokinetic–Pharmacodynamic Relationship: Problems01:24

Pharmacokinetic–Pharmacodynamic Relationship: Problems

The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multidimensional evaluation of large language models on the AAP in-service examination: Assessing accuracy, calibration, and citation reliability.

PLOS digital health·2026
Same author

Contrasting principal stratum and hypothetical strategy estimands in multi-period crossover trials with incomplete data.

Biometrics·2022
Same author

A Health Care System's Approach to Support Nursing Leaders in Mitigating Burnout Amid a COVID-19 World Pandemic.

Nursing administration quarterly·2021
Same author

Degrees of necessity and of sufficiency: Further results and extensions, with an application to covid-19 mortality in Austria.

Statistics in medicine·2021
Same author

Mitigating potential public health problems associated with edible cannabis products through adequate regulation: A landscape analysis.

Critical reviews in food science and nutrition·2020
Same author

Random cancers as supported by registry data.

Statistics in medicine·2020

Related Experiment Videos

Regret-regression for optimal dynamic treatment regimes.

Robin Henderson1, Phil Ansell, Deyadeen Alshibani

  • 1Mathematics & Statistics, Newcastle University, UK. Robin.Henderson@ncl.ac.uk

Biometrics
|December 17, 2009
PubMed
Summary

This study introduces a new strategy for determining optimal dynamic treatment regimes, incorporating regret functions into regression models. This approach allows for model comparison and is demonstrated with anticoagulant dosage optimization.

Related Experiment Videos

Area of Science:

  • Statistics
  • Biostatistics
  • Machine Learning

Background:

  • Dynamic treatment regimes (DTRs) are crucial for personalized medicine, but their determination in practice lacks robust model-building and comparison strategies.
  • Existing literature has largely overlooked the practical aspects of model selection and validation for DTRs.
  • Optimal dosage determination, particularly for anticoagulants, presents a significant challenge requiring advanced statistical methods.

Purpose of the Study:

  • To propose a novel modeling and estimation strategy for optimal dynamic treatment regime determination.
  • To integrate regret functions into regression models for enhanced response analysis.
  • To provide a framework for model building, checking, and comparison in DTR literature.

Main Methods:

  • Developed a regression modeling strategy incorporating Murphy's regret functions (2003).
  • Employed a rapid estimation technique for practical application.
  • Integrated diagnostic tools for comprehensive model evaluation and comparison.

Main Results:

  • The proposed strategy enables efficient estimation and robust model diagnostics.
  • Facilitates the comparison of various candidate models for DTRs.
  • Successfully illustrated the method's utility through simulation studies and a real-world anticoagulation application.

Conclusions:

  • The introduced method offers a practical and adaptable approach to optimal dynamic treatment regime determination.
  • Addresses the gap in model building, checking, and comparison within DTR research.
  • Provides a valuable tool for optimizing treatments, exemplified by anticoagulant dosage management.